You have no items in your shopping cart.
Cart summary
Item 1 of 4
Item 1 of 4
Anti-CD19 Reference Antibody (tafasitamab)
Catalog Number: orb1818352
| Catalog Number | orb1818352 |
|---|---|
| Category | Antibodies |
| Description | Recombinant Antibody |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Conjugation | Unconjugated |
| Reactivity | Human, Monkey |
| Form/Appearance | Purified monoclonal antibody supplied in 100mM Proline/Acetic acid, 20mM Arginine, pH 5.0, without preservative.This antibody is purified through a protein A column. |
| Concentration | 1mg/ml |
| Protein Sequence | CD19 |
| UniProt ID | P15391 |
| MW | 147.42 |
| Tested applications | ELISA, FC |
| Antibody Type | Primary Antibody |
| Expression System | CHO Cell |
| Endotoxins | < 0.001EU/μg,determined by LAL method. |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles |
| Alternative names | B-lymphocyte antigen CD19, B-lymphocyte surface an Read more... |
| Note | For research use only |
The purity of Anti-CD19 Reference Antibody (tafasitamab) is more than 98.59%, determined by SEC-HPLC.
Immobilized human CD19 (20 291) Protein, His Tag at 2 µg/mL can bind Anti-CD19 Reference Antibody (tafasitamab), EC50=0.0904 µg/mL
Anti-CD19 Reference Antibody (tafasitamab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%
Human CD19 HEK293 cells were stained with Anti-CD19 Reference Antibody (tafasitamab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC190=0.085 µg/mL
